Collaboration at Department of Immunology, Genetics and Pathology
Research at IGP is linked to relevant clinical problems with a clear aim to shorten the time between scientific discovery and health gain.
One of the major aims at the department is to perform translational research, bridging basic experimental research and modern diagnostics and therapy. Translational research is promoted by tight collaborations between experimentally and clinically active researchers and the relationship with our affiliated hospital clinics provides excellent conditions for success.
The clinical units are engaged in education of staff categories in the different specialities, which includes research, development and teaching. In this, IGP has an active role and contributes with infrastructure and competence to integrate the University’s and the hospital’s goals.
Collaborative hospital clinics
Clinical genetics
The clinic conducts research and provides expertise on the genetic background for inherited diseases and cancer. Their goal is to clarify the function of genes and molecules in disease mechanisms and to use this knowledge in diagnostics and treatments.
Clinical immunology and transfusion medicine
Research at the clinic focuses on diabetes and other autoimmune diseases, immunological reactions after transplantations and development of immune therapy for cancer.
Clinical pathology
The hospital unit for clinical pathology has a dedicated research and development group that provides services for internal and external clients. These include handling requests for withdrawal of patient samples and microscopic or molecular analyses. The unit has a well-functioning collaboration with IGP researchers and with the strategic research project U-CAN.
Oncology
At the oncology clinic patients with cancer receive their treatment and many doctors at the clinic perform research on tumour diseases and cancer therapies. An important part of the clinic is the clinical research and development unit that provides assistance and knowledge in clinical drug trials of and other clinical studies.
Skandionkliniken
Skandionkliniken conducts research projects that evaluate the effects of proton beam therapy. The research aims, among other things, to improve treatment results and patients’ quality of life.